chevron_leftBack
As of 24 April 2025, Carmat S.A. has a market cap of $58.29M USD, ranking #23828 globally and #342 in France. It ranks #2414 in the Healthcare sector, and #294 in the Medical Devices industry.
Key Stats
Market Cap
$58.29MUSD
51.22M EUR
Enterprise Value
$111.87MUSD
98.3M EUR
Revenue (TTM)
$7.88MUSD
6.93M EUR
EBITDA (TTM)
-$57.12MUSD
-50.2M EUR
Net Income (TTM)
-$60.71MUSD
-53.35M EUR
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Stephane Piat
open_in_new
Employees
182
Founded
2008
Website
carmatsa.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.5% | -1.3% | 0.3% | -19% | -40% | -77% |
Upcoming Earnings
Earnings Date
Wed, Apr 30
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ALCAR
Carmat
ISIN: FR0010907956
Shares Out.:
Shares Outstanding:
58.818M1
Shares Float:
47.633M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.8750 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Carmat S.A.
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
